Table 5.
First diet | Vegan supplemented | With protein- free food | Other | All cases | p Among groups |
---|---|---|---|---|---|
n | 83 | 12 | 10 | 105 | |
Males/Females (%) | 52 (62.7%) 31 (37.3%) |
8 (66.7%) 4 (33.3%) |
4 (40.0%) 6 (60.0%) |
64 (61.0%) 41 (39.0%) |
0.348 |
Age at start of diet: median (min max) | 63 (23–86) | 72 (59–86) | 69.5 (29–83) | 64 (23–86) | 0.009 |
Age over 65 (%) | 32 (38.6%) | 9 (75.0%) | 6 (60.0%) | 47 (44.8%) | 0.036 |
Age over 80 (%) | 4 (4.8%) | 2 (16.7%) | 1 (10.0%) | 7 (6.7%) | 0.278 |
Charlson index median (min max) | 6 (2–11) | 7.5 (5–12) | 8 (4–10) | 6 (2–12) | 0.001 |
Charlson > =7 (%) | 30 (36.1%) | 9 (75.0%) | 8 (80.0%) | 47 (44.8%) | 0.003 |
Charlson > =10 (%) | 5 (6.0%) | 3 (25.0%) | 1 (10.0%) | 9 (8.6%) | 0.089 |
Diabetes (%) | 23 (27.7%) | 7 (58.3%) | 4 (40.0%) | 34 (32.4%) | 0.091 |
Cardiopathy (%) | 26 (31.3%) | 6 (50.0%) | 6 (60.0%) | 38 (36.2%) | 0.117 |
Neoplasia (%) | 16 (19.3%) | 2 (16.7%) | 6 (60.0%) | 24 (22.9%) | 0.013 |
s Creatinine (mg/dL) median, (min-max) | 4.5 (1.5–16.0) | 3.3 (2.3–6.4) | 3.6 (2.5–6.7) | 4.2 (1.5–16.0) | 0.492 |
eGFR-EPI (mL/min) median, (min-max) | 12.8 (3.0–44.6) | 16.2 (7.7–25.5) | 15.1 (5.7–19.7) | 13.2 (3.0–44.6) | 0.885 |
Proteinuria (g/day) median, (min-max) | 1.5 (0.1–9) | 1.4 (0.7–5.7) | 3.3 (0.1–11) | 1.5 (0.1–11) | 0.407 |
Proteinuria > =1 g/day (%) | 55 (67.9%) | 8 (66.7%) | 7 (70.0%) | 70 (68.0%) | 0.986 |
Proteinuria > =3 g/day (%) | 21 (25.9%) | 4 (33.3%) | 5 (50.0%) | 30 (29.1%) | 0.270 |
Glomerulonephritis-systemic disease (%) | 26 (31.3%) | 2 (16.7%) | 2 (20.0%) | 30 (28.6%) | 0.472 |
Nephroangiosclerosis and/or diabetes (%) | 37 (44.6%) | 10 (83.3%) | 5 (50.0%) | 52 (49.5%) | 0.043 |
ADPKD (%) | 7 (8.4%) | 0 (0.0%) | 2 (20.0%) | 9 (8.6%) | 0.247 |
Type of dialysis (% HD) | 71 (85.5%) | 10 (83.3%) | 10 (100%) | 91 (86.6%) | 0.457 |
dialysis in emergency n (%) | 3 (3.6%) | 0 | 0 | 3 (2.8%) | 0.630 |